IDH2 and neoplasm: Our data demonstrate that the mIDH enzyme remains active in recurrent disease, because 2-HG reduction was associated with reduced tumor cell proliferation, increased DNA 5hmC content (mediated by TET 5mC hydroxylase activity)23 and a reversal of gene expression programs typically associated with IDH mutations in LGGs.